Roger Lachance

679 total citations
26 papers, 546 citations indexed

About

Roger Lachance is a scholar working on Endocrinology, Diabetes and Metabolism, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Roger Lachance has authored 26 papers receiving a total of 546 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Pulmonary and Respiratory Medicine and 6 papers in Molecular Biology. Recurrent topics in Roger Lachance's work include Hormonal and reproductive studies (11 papers), Prostate Cancer Treatment and Research (9 papers) and Sexual Differentiation and Disorders (5 papers). Roger Lachance is often cited by papers focused on Hormonal and reproductive studies (11 papers), Prostate Cancer Treatment and Research (9 papers) and Sexual Differentiation and Disorders (5 papers). Roger Lachance collaborates with scholars based in Canada and Russia. Roger Lachance's co-authors include Fernand Labrie, André Dupont, Alain Bélanger, A. De Léan, Jacques Drouin, Roch P. Boivin, Van Luu‐The, Donald Poirier, A. Bèlanger and Naomi Fitch and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Endocrinology and Journal of Medicinal Chemistry.

In The Last Decade

Roger Lachance

26 papers receiving 495 citations

Peers

Roger Lachance

EDM

PRM

GENET

Marina Rodríguez Spain

Li‐Qun Cai United States

A. W. Brandenberger Switzerland

Farida Mébarki France

Margaret Monahan United Kingdom

Hernan F. Acevedo United States

Bruce C. Moulton United States

Robert Benveniste United States

Carl Turgeon Canada

Hadley Kirkman United States

Marina Rodríguez Spain

Roger Lachance

102 ×0.4

EDM

94 ×0.6

PRM

87 ×0.7

GENET

211 ×1.7

130 ×1.4

Citations per year, relative to Roger Lachance Roger Lachance (= 1×) peers Marina Rodríguez

Countries citing papers authored by Roger Lachance

Since Specialization

Citations

This map shows the geographic impact of Roger Lachance's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger Lachance with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger Lachance more than expected).

Fields of papers citing papers by Roger Lachance

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger Lachance. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger Lachance. The network helps show where Roger Lachance may publish in the future.

Co-authorship network of co-authors of Roger Lachance

This figure shows the co-authorship network connecting the top 25 collaborators of Roger Lachance. A scholar is included among the top collaborators of Roger Lachance based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger Lachance. Roger Lachance is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Labrie, Fernand, André Dupont, L. Cusan, et al.. (1988). Combination therapy with flutamide and castration (LHRH agonist or orchiectomy) in previously untreated patients with clinical stage D2 prostate cancer: Today's therapy of choice. Journal of Steroid Biochemistry. 30(1-6). 107–117. 19 indexed citations

Labrie, Fernand, M. Giguère, Yves Lacourcière, et al.. (1988). Combination therapy with flutamide and castration (orchiectomy or LHRH agonist): the minimal endocrine therapy in both untreated and previously treated patients with advanced prostate cancer.. PubMed. 260. 41–62. 6 indexed citations

Labrie, Fernand, André Dupont, L. Cusan, et al.. (1988). Important prognostic value of standardized objective criteria of response in stage D2 prostatic carcinoma. European Journal of Cancer and Clinical Oncology. 24(12). 1869–1878. 11 indexed citations

Labrie, Fernand, A. Dupont, M. Giguère, et al.. (1987). Combination therapy with flutamide and castration (orchiectomy or LHRH agonist): the minimal endocrine therapy in both untreated and previously treated patients. Journal of Steroid Biochemistry. 27(1-3). 525–532. 16 indexed citations

Labrie, Fernand, André Dupont, Alain Bélanger, & Roger Lachance. (1987). Flutamide Eliminates the Risk of Disease Flare in Prostatic Cancer Patients Treated with a Luteinizing Hormone-Releasing Hormone Agonist. The Journal of Urology. 138(4 Part 1). 804–806. 92 indexed citations

St‐Arnaud, René, Roger Lachance, & Fernand Labrie. (1987). Characteristics of Radioimmunoassays for the α- and β-Subunits of Human Luteinizing Hormone. Journal of Immunoassay. 8(1). 97–114. 1 indexed citations

Lachance, Roger. (1986). Anaphylaxis due to vaccination in the office. Canadian Medical Association Journal. 134(10). 1109–1109. 6 indexed citations

St‐Arnaud, René, et al.. (1986). LOSS OF LUTEINIZING HORMONE BIOACTIVITY IN PATIENTS WITH PROSTATIC CANCER TREATED WITH AN LHRH AGONIST AND A PURE ANTIANDROGEN. Clinical Endocrinology. 24(1). 21–30. 25 indexed citations

Arnaud, René, Roger Lachance, André Dupont, & Fernand Labrie. (1986). Serum Luteinizing Hormone (LH) Biological Activity in Castrated Patients with Cancer of the Prostate Receiving a Pure Antiandrogen and in Estrogen-Pretreated Patients Treated with an LH-Releasing Hormone Agonist and Antiandrogen. The Journal of Clinical Endocrinology & Metabolism. 63(2). 297–302. 19 indexed citations

10.

Labrie, Fernand, A. Dupont, A. Bèlanger, Roger Lachance, & M. Giguère. (1986). Long Term Treatment With Luteinising Hormone Releasing Hormone Agonists and Maintenance of Serum Testosterone to Castration Concentrations. The Journal of Urology. 135(6). 1339–1339. 2 indexed citations

11.

Labrie, Fernand, A. Dupont, A. Bèlanger, Roger Lachance, & M. Giguère. (1985). Long term treatment with luteinising hormone releasing hormone agonists and maintenance of serum testosterone to castration concentrations.. BMJ. 291(6492). 369–370. 34 indexed citations

12.

St‐Arnaud, René, Roger Lachance, A. Bèlanger, A Dupont, & Fernand Labrie. (1984). Pituitary desensitization and loss of luteinizing hormone bioactivity in men with cancer of the prostate following chronic treatment with an lhrh agonist and an antiandrogen. Journal of Steroid Biochemistry. 20(6). 1408–1408. 2 indexed citations

13.

Lachance, Roger. (1984). A Nation at Risk—A Principal's Viewpoint. NASSP Bulletin. 68(470). 45–48. 1 indexed citations

14.

Ainsworth, L., Roger Lachance, & Fernand Labrie. (1983). Effects of progestagen treatments and PMSG on the induction of the preovulatory LH discharge in ewes. Animal Reproduction Science. 5(4). 281–286. 11 indexed citations

15.

Ainsworth, L., et al.. (1982). Effect of GnRH-Induced Endogenous Luteinizing Hormone Release and Exogenous Progestogen Treatment on Ovarian Activity in the Postpartum Ewe. Journal of Animal Science. 54(5). 998–1004. 6 indexed citations

16.

Wolkove, Norman, et al.. (1981). Choriocarcinoma presenting as hemothorax.. PubMed. 124(12). 1599–600. 5 indexed citations

17.

Massicotte, Jocelyne, et al.. (1981). Inhibition of hCG-induced cyclic AMP accumulation and steroidogenesis in rat luteal cells by an LHRH agonist. Journal of Steroid Biochemistry. 14(3). 239–242. 23 indexed citations

18.

Drouin, Jacques, et al.. (1976). Characteristics of the Interaction Between Thyrotropin-Releasing Hormone and Somatostatin for Thyrotropin and Prolactin Release. Endocrinology. 98(2). 514–521. 94 indexed citations

19.

Lachance, Roger, et al.. (1976). Masculinizing granulosa cell tumour.. PubMed. 115(6). 545–6. 10 indexed citations

20.

Lachance, Roger, et al.. (1969). [A case of hypomagnesemia in a newborn].. PubMed. 40(10). 1037–44. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact